Programme Thesis
This programme funds doctoral training in pharmacology at the University of Manchester, supporting research into drug actions, mechanisms, and therapeutic applications. It exists to train the next generation of pharmacology researchers within collaborative centres of excellence, addressing real-world challenges in drug discovery and safety.
Selection Criteria
- Academic excellence: Upper Second class Honours (or equivalent) in a related subject; Lower Second may be considered with a Master's at Merit.
- English language proficiency: IELTS 6.5 overall (min 5.5 in each component) or TOEFL iBT 90 (min 22 in each component, writing min 6.0).
- Research alignment: fit with faculty research groups (e.g., Centre for Applied Pharmacokinetic Research, North West Centre for Advanced Drug Delivery).
- Supervisor availability: applicants must secure a supervisor and project; funded studentships are competitive and project-specific.
- For funded studentships: additional criteria set by the funding body (e.g., UKRI eligibility for home fees).
Past Winners / Cohort Profiles
Past cohorts typically include recent graduates with strong undergraduate records in pharmacology, pharmacy, or related biomedical sciences, often with prior research experience (e.g., lab placements, master's projects). Named examples are not listed on the page, but funded studentships are awarded to candidates whose research proposals align with faculty expertise and who demonstrate potential for independent research.
Ideal Candidate Fingerprint
The ideal applicant holds a strong Upper Second or First Class degree in pharmacology or a related field, has relevant research experience (e.g., in drug action, pharmacokinetics, or drug delivery), and presents a compelling research proposal that aligns with one of the faculty's research centres. They are highly motivated, have secured a supportive supervisor, and meet all English language requirements.
Recommended Framing
For Eniola, the strongest angle is to leverage the CCT model as the core research proposal, directly aligning with the programme's focus on drug mechanisms and therapeutic applications in addiction neuroscience. This line demonstrates a sophisticated computational pharmacology approach, with pre-registered hypotheses and Bayesian calibration, which would appeal to supervisors in the Centre for Applied Pharmacokinetic Research or neuropharmacology groups. The fit is strong because the CCT model addresses a real-world challenge (addiction) using quantitative methods, matching the programme's emphasis on investigating drug actions and signaling pathways.
Watch Out
Timing: Eniola is enrolled in a Master's starting Winter 2026/27, which may conflict with a September 2026 PhD start. Funding: International fees are high (£27,000+ per annum), and the programme does not guarantee funding; Eniola would need to secure a funded studentship or external scholarship. English language: Must provide IELTS/TOEFL scores meeting minimums, which may require testing. Competition: As an independent researcher without a formal PhD supervisor, securing a supervisor and project may be challenging.
Research History
2026-08-04 20:17 · medium confidence
2026-08-01 17:33 · medium confidence